Background. The use of donation after circulatory death (DCD) donors for lung
Introduction
There has been a progressive increase in the number of patients on the waiting list, which continually exceeds the number of available organs. The use of DCD donors has been employed to resolve this problem (1) (2) (3) (4) (5) . Severe warm ischemia reperfusion injury may lead to primary graft dysfunction, and remains a significant cause of early morbidity and mortality after lung transplantation (6, 7) . The inhibition of warm ischemia reperfusion injury is, therefore, crucial to facilitate lung transplantation from DCD donors.
The principle of EVLP is to recreate the physiological environment by maintaining normothermia and providing the essential substrates for cellular metabolism. Therefore, EVLP enables organ viability assessment, prolonged preservation, and resuscitation from injuries before transplantation. Steen and colleagues developed an ex vivo system for evaluating the functions of DCD lungs before transplantation, and successfully performed lung transplantation from an uncontrolled DCD donor in 2000 (8) . Cypel and colleagues established a successful prolonged EVLP system (9) . EVLP can also provide access for the administration of cytoprotective and immunomodulatory drugs, and can allow for both the pretreatment and reconditioning of marginal donor lungs (10) .
We simulated a clinically relevant uncontrolled DCD model in the current study. We have previously reported the protective effects of nitroglycerin (NTG) and dibutyryl cyclic adenosine monophosphate (db-cAMP) for ischemia reperfusion injury (11) (12) (13) . In this study, we investigated whether EVLP using the STEEN solution with NTG and db-cAMP would resuscitate DCD lungs after warm ischemia, 4 and would ameliorate ischemia reperfusion injury.
Materials and Methods

Animals
Beagles weighting from 9 to 15 kg (Kitayama Labes Co. Ltd., Hongo Farm, Yamaguchi, Japan) were used in this study. ventilator and left open to the air after cardiac arrest. Therefore, the donor lungs kept collapsed completely during 4 h of warm ischemia. Four hours after cardiac arrest, the mechanical ventilation was resumed as described above, the main pulmonary artery was cannulated, the superior and inferior vena cava were tied, and the left atrial appendage was incised. Antegrade and retrograde flushes of the lungs were performed with 1,000 ml and 500 ml of ET-Kyoto solution (Otsuka Pharmaceutical Factory Inc, Tokushima, Japan), respectively. After the donor lungs were retrieved, they were divided into 2 groups (n=6 each): static cold storage with ET-Kyoto solution at 4℃ for 3.5 h (SCS group) or normothermic EVLP for 3.5 h (EVLP group). In both groups, the left lung was then transplanted to a recipient.
The bronchial anastomosis was performed first with a running 5-0 PDS suture, the left atrial anastomosis was performed next with a running 6-0 prolene suture, and then the pulmonary arterial anastomosis was performed with a running 6-0 prolene suture. The implantation time was set for 60 min. After the transplanted lung was reinflated and mechanically ventilated as described above, the PA clamp was gradually removed and the transplanted lung was reperfused for 4 h to evaluate the posttransplant lung functions. The right pulmonary artery was occluded with a tourniquet at 45 min of reperfusion to specifically evaluate the functions of the transplanted lung.
Ex vivo lung perfusion (EVLP) EVLP was performed as described by Cypel and colleagues (14) . The lungs were placed in the XVIVO chamber (Vitrolife, Denver, CO). The trachea was intubated and connected to the ventilator. The pulmonary artery and left atrial appendage were cannulated directly and connected to the perfusion circuit. The EVLP perfusate consisted of STEEN solution (1,500 ml) with methylprednisolone (500 mg), heparin (10,000 IU), cefazolin (500 mg), db-cAMP (1,500 mg), and NTG (75 mg). The perfusate was driven by a centrifugal pump at a constant flow rate. The perfusate flow was initiated at 10% of the full flow rate at room temperature. The temperature of the perfusate was gradually increased to 37 ℃ . When the temperature of the perfusate reached 32℃, ventilation was started with a FiO2 of 0.21, tidal volume of 10 ml/kg, frequency of 10 breaths/min and PEEP of 5 cmH2O, and the deoxygenation of the perfusate from the lungs was started with a gas mixture of nitrogen (86%), carbon dioxide (8%), and oxygen (6%). The perfusate flow rate was gradually increased to the full flow rate which was 40% of estimated cardiac output (CO = 100 ml/kg). EVLP at the full flow rate was conducted for 90 min. The time point at which the perfusion flow reached the full flow rate was defined as the base line (BL), and the physiological lung functions during EVLP were evaluated every 30 min. The pulmonary arterial pressure, left atrial pressure, and peak airway pressure were all continuously monitored, and the left atrial pressure was maintained at 3 to 5 mmHg throughout the experiments. Dynamic pulmonary compliance was defined as tidal volume/(PawP-PEEP) (ml/cmH2O). A blood gas analysis of the perfusate to and from the lungs was performed every 30 min after 10 min exposure to FiO2 of 1.0. The temperature of the perfusate was cooled down to 20℃ after the last evaluation, and then perfusion and ventilation were stopped. The donor lungs semiinflated with air were then stored in ET-Kyoto solution at 4℃ until transplantation.
Posttransplant lung functions
The pulmonary arterial pressure and peak airway pressure were continuously 7 monitored throughout the experiments. Dynamic pulmonary compliance was defined as described above. A blood gas analysis was performed from the femoral artery and pulmonary artery at given time points. Lung tissue biopsy samples collected from the left lower lobe 4 h after transplantation were weighed as the wet lung weight, placed in an oven at 180℃ for 24 h, and then reweighed as the dry lung weight. The wet to dry lung weight ratio was calculated to evaluate the presence of lung edema.
Histological evaluation of microthrombi before transplantation and ischemia reperfusion injury
Lung tissue biopsies were collected from the right upper lobe before transplantation and the left upper lobe 4 h after transplantation to microscopically evaluate the formation of microthrombi in the donor lungs before transplantation and ischemia reperfusion injury after transplantation. They were fixed in 10% buffered formalin, embedded in paraffin, and stained with hematoxylin and eosin. Ischemia reperfusion injury was scored blindly by two investigators (D.N. and J.S.) using a four-point scale according to the combined assessment of edema (interstitial and intra-alveolar congestion), hemorrhage, inflammatory cell infiltration, and hyaline membrane formation: 0 = absent, 1 = mild, 2 = moderate, 3 = severe damage (15, 16) .
Lung tissue energy levels
Lung tissue biopsies were collected from the right lower lobe before cardiac arrest and after warm ischemia, and then were collected from the left lower lobe 4 h after transplantation. The levels of adenosine triphosphate (ATP) were measured by high-performance liquid chromatography using a Shim-pack CLC-ODS column (15 cm×6 .0 mm; Shimadzu, Japan) and 100 mM sodium phosphate buffer (PH 6.0) at a wavelength of 260 nm, as previously described (17) .
Statistical analysis
All data are presented as the means ± standard deviation. The statistical analysis was performed by Student's t-test, the Mann-Whitney U test, and the χ 2 test. A p value less than 0.05 was considered to be statistically significant.
Results
Physiological lung functions
One beagle died due to severe pulmonary edema 2.5 h after transplantation in each group. These two animals were excluded from the data analysis 3 h and 4 h after transplantation.
Lung oxygenation was significantly improved by EVLP (p < 0.01; Figure 1A ).
In detail, the PaO2 at the baseline of EVLP and the end of EVLP were 437 ± 68 mmHg and 558 ± 35 mmHg, respectively. The dynamic pulmonary compliance and pulmonary vascular resistance were stable during EVLP (Figures 1B and C) .
The posttransplant lung oxygenation was significantly better in the EVLP group than that in the SCS group 3 h and 4 h after transplantation (p < 0.05; Figure   2A ). The dynamic pulmonary compliance 4 h after transplantation was significantly better in the EVLP group than that in the SCS group (EVLP group 13.02 ± 0.99 ml/cmH2O, SCS group 11.26 ± 0.99 ml/cmH2O; p < 0.05; Figure 2B ). The wet to dry lung weight ratio 4 h after transplantation was also significantly lower in the EVLP group than that in the SCS group (EVLP group 6.30 ± 0.54, SCS group 10.92 ± 0.86; p < 0.01; Figure 2C ).
The lung oxygenation at the end of EVLP was significantly correlated with the lung oxygenation 4 h after transplantation (r = 0.99, p < 0.01; Figure 3A) . However, there was no significant correlation between the dynamic pulmonary compliance at the end of EVLP and that 4 h after transplantation (r = 0.55, p = 0.33; Figure 3B ).
Histological findings of ischemia reperfusion injury
Severe interstitial and intra-alveolar edema, hemorrhage, infiltration or aggregation of inflammatory cells in the air space or vessel wall, and hyaline formation were detected in the SCS group 4 h after transplantation ( Figures 4A and   B ). The acute lung injury score was significantly lower in the EVLP group compared with the SCS group (EVLP group: 24.5 ± 3.1, SCS group: 32.3 ± 6.4, p=0.03; Figure 4C ).
The formation of microthrombi before transplantation
In the macroscopic findings, the surface of donor lungs looked uniformly perfused 90 min after EVLP (Figures 5A and B) . In the donor lungs before transplantation, residual blood cells or blood clots were microscopically observed more often in the SCS group compared with the EVLP group ( Figures 6A and B) .
Lung tissue energy level
In the EVLP group, the lung tissue ATP levels which decreased during warm ischemia were improved to the normal levels observed before cardiac arrest 4 h after transplantation (Figure 7) . The lung tissue ATP levels 4 h after transplantation were significantly higher in the EVLP group compared with the SCS group (p = 0.03; Figure 7 ). The ATP levels before cardiac arrest and after warm ischemia were 3.27±0.37 and 1.67±0.55 nmol/mg, respectively. The ATP levels 4 h after transplantation in the EVLP group and in the SCS group were 3.27±0.54, and 2.37±0.49 nmol/mg, respectively.
Discussion
This study demonstrated that normothermic EVLP with db-cAMP and NTG could resuscitate DCD lungs injured by 4 h of warm ischemia, and could ameliorate ischemia reperfusion injury compared with static cold storage. Cypel and colleagues have established a successful prolonged EVLP system using an acellular perfusate, and suggested that this system can be used to assess, maintain, and treat injured donor lungs (14) . We also have adapted their technique, and confirmed excellent lung performance during 8 h of EVLP (unpublished data). The current study found that the lung oxygenation at the end of EVLP was significantly correlated with the lung oxygenation after transplantation, and thus our EVLP system can be useful to evaluate the oxygenation of DCD lungs before transplantation. Cypel and colleagues recently demonstrated in their clinical study that lung transplantation using high risk donor lungs that are stable physiologically during 4 h of EVLP led to results similar to conventional lung transplantation (18) . In their study, lung oxygenation in high risk donor lungs was improved 1-2 h after EVLP. Steen and colleagues demonstrated that EVLP could be used for reconditioning of initially rejected donor lungs, and the median reconditioning time was 1 hour and 29 minutes (19) . Therefore, in the current study, EVLP at a full flow rate was conducted for 1 hour 30 minutes. We found that the lung oxygenation was significantly improved by short-term EVLP, and that the other lung functions were stable during EVLP. EVLP can provide access for the administration of cytoprotective drugs, and can perform pretreatment and reconditioning of marginal donor lungs (24, 25) . In the current study, db-cAMP and NTG were included in the perfusate. A previous study demonstrated that the intracellular cAMP levels were decreased in DCD lungs (17) . Db-cAMP elevates the intracellular levels of cAMP, which acts as a second messenger in suppressing vascular permeability, relaxing vascular smooth muscle, and suppressing neutrophil adhesion to the vascular wall (13) . On the other hand, NTG works in vivo as an NO donor. NO stimulates the production of cGMP, which acts as an intracellular second messenger for relaxing vascular smooth muscle, inhibiting platelet adhesion and aggregation, and adjusting the vascular permeability (12).
Oxidative energy production by mitochondrial electron transport would still be sustained to some extent at hypothermia. Therefore, lung cells are able to maintain aerobic metabolism using the oxygen present in the alveoli during preservation (26) .
In the SCS group, the lung ATP levels which decreased during warm ischemia were improved, but did not reach the normal levels after transplantation. EVLP washed out the residual microthrombi in the donor lungs, thus resulting in a more uniform distribution of the preservation solution, including nutrition. As a result, ATP synthesis was completely restored in the whole lung cells during normothermic EVLP, and the ATP levels decreased during warm ischemia were improved to the normal levels after transplantation. It might be easier to prove the metabolic benefits of EVLP, if the ATP levels after warm ischemia were compared to those at the end of EVLP. Energy charges maintain the homeostasis and structural competence of the vasculature and parenchymal cell interactions, and marginal donor lungs can maintain their integrity of the structural elements necessary to recover from various injuries.
This study had several limitations. First, although we simulated a clinically relevant uncontrolled DCD model, cardiac arrest was induced by the intravenous injection of potassium chloride. Such an abrupt cardiac arrest might be removed from the clinical reality in that there was not an agonal phase which is an almost invariable component of DCD. Second, EVLP was performed immediately after 13 organ retrieval. Clinical practice may require some additional time for donor lungs to be transported from a donor hospital to a transplant center. Thus, EVLP may be effective after static cold storage, just before lung transplantation in a transplant center. Third, the addition of db-cAMP and NTG in the perfusate resulted in an inability to conclusively prove that EVLP alone was responsible for all of the benefits observed in this study. How much these additional additives contributed to the benefits of EVLP would require further study. Finally, one beagle died due to pulmonary edema after transplantation in the EVLP group, as well as in the SCS group. The reason why EVLP could not resuscitate the donor lungs, and could not reduce the ischemia reperfusion injury in the fatal case therefore requires further study.
In conclusion, short-term EVLP washed out residual pulmonary microthrombi, and restored the lung tissue ATP levels which decreased during warm ischemia to the normal levels. As a result, DCD lungs could be resuscitated after warm ischemia, and ischemia reperfusion injury could therefore be ameliorated with short-term EVLP.
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